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ABSTRACT
There is a heated debate on how to interpret the decisions
provided by deep learning models (DLM), where the main
approaches rely on the visualization of salient regions to
interpret the DLM classification process. However, these
approaches generally fail to satisfy three conditions for the
problem of lesion detection from medical images: 1) for
images with lesions, all salient regions should represent
lesions, 2) for images containing no lesions, no salient
region should be produced, and 3) lesions are generally small
with relatively smooth borders. We propose a new model-
agnostic paradigm to interpret DLM classification decisions
supported by a novel definition of saliency that incorporates
the conditions above. Our model-agnostic 1-class saliency
detector (MASD) is tested on weakly supervised breast
lesion detection from DCE-MRI, achieving state-of-the-art
detection accuracy when compared to current visualization
methods.
Index Terms— saliency, weakly supervised detection,
model interpretability, diagnosis explanation, breast lesion
localization, breast magnetic resonance imaging.
1. INTRODUCTION
There is growing debate concerning the interpretation of
classifications made by deep learning models (DLM) [1],
particularly in medical diagnosis systems that can directly
influence treatment decisions [2]. The clinical acceptance of
DLMs depends, among other factors, on a reliable explana-
tion of the model outcomes [3]. A popular approach that can
”explain” DLM predictions relies on a salient region detec-
tor [4]. Such weakly supervised DLMs are trained to perform
binary classification (negative: no lesion, positive: lesions)
and produce salient regions that are assumed to highlight
the regions responsible for the positive classification [4].
However, this assumption is unwarranted for two reasons.
For positive classifications, there is no guarantee that salient
regions represent lesions, and for negative volumes, salient
regions have an unclear meaning. We argue that these issues
stem from the fact that saliency is poorly defined for weakly
supervised DLMs, where the training set contains images
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with global annotations (i.e image-level labels), but no lesion
delineation.
We propose a new paradigm for explaining DLM clas-
sifications supported by a novel saliency definition for the
problem of lesion detection. We define saliency as an image
region that is responsible for a positive classification as
opposed to previous saliency definition that was simply
assumed to be active image regions during classification.
Our new model-agnostic 1-class saliency detector (MASD)
is explicitly trained to detect lesions from volumes that have
been classified by a separate DLM (see Fig. 1 - note that
MASD is independent of the DLM classifier, which is the
reason why we call it model-agnostic). This goal is achieved
by explicitly defining salient regions as follows: 1) they
only appear when the volume is positively classified; 2)
they have a small area and a relatively smooth boundary; 3)
when used to mask a positively classified volume, it remains
positively classified; and 4) when the inverted salient regions
are used to mask a positively classified volume, it becomes
negatively classified. The design of MASD is adapted from
recent saliency detectors [5], [6] to become a 1-class saliency
detector by incorporating our saliency definition above. We
test our approach on two weakly supervised lesion detection
problems from breast dynamic contrast-enhanced magnetic
resonance volumes (DCE-MRI): 1) (benign and malignant)
lesion detection, and 2) malignant lesion detection. We show
that our results are more accurate than the ones produced
by the following state-of-the-art (SOTA) saliency detectors:
CAM [7], a popular approach for weakly supervised detec-
tion; Grad-CAM and Guided-GRAD-CAM [8], which are
two extensions that improve upon CAM.
2. LITERATURE REVIEW
DCE-MRI is recommended as a complementary imag-
ing modality for screening patients at high-risk for breast
cancer [9]. Computer-aided detection methods have been
designed [10], [11], [12], [13] and trained with strong (voxel-
wise) annotations to assist radiologists. As strong annota-
tions are time consuming and noisy, this approach does
not scale to the large datasets necessary for deep learning
systems. An alternative approach is to use the large weakly
labeled datasets that are more readily available. The main
challenge behind this approach is the requirement that the
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Fig. 1: During inference (a), the weakly trained DLM produces a classification for the presence of a breast lesion – if the
classification is positive, our proposed MASD outputs a saliency map that highlights the regions containing lesions. The
training for volumes containing lesions in (b) is based on a loss function that penalizes: 1) saliency maps that are not smooth
and contain large regions, 2) negative classification from the input volume filtered by the saliency map, and 3) positive
classifications from the input volume filtered by the inverse of the saliency map. The training process for volumes that do
not contain lesions penalizes the presence of any active region in the saliency map.
classifier should not only classify the case, but also highlight
the region containing the lesion for the positive cases.
The medical imaging community has addressed this chal-
lenge by exploring saliency detectors [14], [15]. These
approaches are based on highlighting regions of an image
that are involved in the classification of each visual class by
looking at the activations [7]. However, they do not work
well when searching for tumors in breast DCE-MRI (given
their inconsistency in shape and appearance [16]). Other
approaches addressed these issues [17], [8], but none of them
consider the major weakness of such saliency detection – the
assumption that salient regions represent lesions.
Dabkowski and Gal [5] extended the work by Fong et
al. [6] by guaranteeing that salient regions represented the
visual class associated with the classification by explicitly
defining saliency. They introduced a saliency loss function
that finds a saliency mask such that: 1) the classification
confidence is not perturbed when the image is masked and 2)
the classification confidence is reduced when masked image
regions are removed. However, there is no definition for
tumors and lesions that address the characteristics of saliency
in medical images. We propose a 1-class saliency detector
that is able to interpret the classification of breast DCE-MRI
volumes to detect lesions. Our main contribution lies on the
explicit definition of saliency based on the definition of a
breast lesion that then allows the definition of an appropriate
loss function.
3. METHODOLOGY
3.1. Dataset
The DCE-MRI dataset is defined by D ={(
xi, ti, {s(j)i }Sij=1, bi, yi
)}N
i=1
, where ti : Ω → R
represents the T1-weighted volume (with Ω being the volume
lattice), xi : Ω→ R denotes the DCE-MRI first subtraction
volume, the segmentation map s(j) : Ω→ {0, 1} is a binary
volume indicating the presence or absence of lesion at each
voxel for one of patient i’s Si lesions (note that we use this
annotation only for testing our approach – not for training),
Fig. 2: MASD model diagram.
bi ∈ {left, right} indicates if this is the left or right breast of
the patient, and yi ∈ Y = {0, 1, 2} denotes the breast label
(yi = 2: breast contains a malignant lesion, yi = 1 : breast
contains at least one benign and no malignant findings,
and yi = 0 : no findings). We consider two scenarios: 1)
lesion detection, where labels y ∈ {1, 2} are joined into
the positive class, and y = 0 represents the negative class;
and 2) malignant lesion detection, where labels y ∈ {0, 1}
are joined into the negative class, and y = 2 represents the
positive class. We divide D in a patient wise manner into
training, validation and testing with no overlap between sets.
3.2. Model Agnostic 1-class Saliency Detector (MASD)
Our proposed MASD model adapts the saliency detector
of Dabkowski and Gal [5] to work as a 1-class detector.
The saliency detector in [5] uses a encoder-decoder structure
with skip connections. The encoder is fixed and trained
to produce the classification of the input image, and the
decoder generates a mask of the same size of the input and
is trained with a loss function that implements the saliency
loss described in the last paragraph of Sec. 2. In [5], the
encoder and decoder are connected through a class selector
at the lowest resolution, indicating the visual classes of the
salient regions.
Our model (see Fig. 2) uses a similar structure but
with no class selector. The encoder consists of a four-
block DenseNet [18] trained for the corresponding weakly
supervised classification problem. The decoder consists of
four blocks, with each block comprising a feature map resize,
a convolution layer, a batch normalization layer and ReLU
activation [19] – the decoder outputs the saliency mask
m : Ω → [0, 1]. Our contribution lies in the removal of the
class selector and modification of the loss function to become
a 1-class saliency detector that produces salient regions with
the lesion properties defined in Sec 1 (2nd paragraph). The
loss function used during training for each sample i is:
`i(m) =λ1`TV (m) + λ2`A(m)− yiλ3`P (m,xi)
+ yiλ4`D(1−m,xi), (1)
where `TV (m) denotes the total variation of the mask and
encourages detected regions to be relatively smooth, `A(m)
computes the area of salient regions and penalizes large
regions in the mask, `P (m,xi) = logP (y = 1|φ(m,x))
aims to maximize the positive classification when the input
volume is masked with the saliency mask (i.e. φ(m,x)), and
`D(1 −m,xi) = P (y = 1|φ(1 −m,x)) aims to minimize
the positive classification when the regions of the mask are
removed from the volume. The loss function (1) is designed
for the model to become a 1-class saliency detector and
respond only to a single class (i.e lesions). It minimizes the
number and area of regions in both negative and positive
volumes and masks only positive volumes (avoiding the class
selector), which are the ones containing salient regions. Note
that yi = 0 switches off `P and `D losses so that volumes
classified as negative will not produce any salient regions.
During inference, the saliency mask is generated with a
forward pass of the whole architecture, and we threshold
the output mask m and form m(τ) : Ω → {0, 1}, such that
m
(τ)
ijk = 1, if mijk > τ , and m
(τ)
ijk = 0, otherwise.
4. EXPERIMENTS AND RESULTS
The dataset used to assess MASD contains 117 DCE-
MRI and T1-weighted volumes (one DCE-MRI and one
T1-weighted volume per patient) [12], [11]. The training,
validation and test set contain 45, 13, and 59 patients [11]
respectively. The number of lesions for each of the above sets
is 57 (38 malignant (m) and 19 benign (b)), 15 (11 m and
4 b), and 69 (46 m and 23 b). The T1-weighted volume is
used to automatically extract the left and right breasts into
separate volumes of 100 × 100 × 50 voxels [11], and the
DCE-MRI volume is used for the classification and lesion
detection approaches.
For the MASD model, the localization is performed only
on positively classified samples, defined by a probability of
being positive higher than the equal error rate (EER) of the
classifier. Note that EER is computed using the validation
set. We perform experiments on the two problems defined in
Sec. 3.1: lesion detection and malignant lesion detection.
We train a DenseNet as the base classifier for each of the
problems. The parameters, estimated with the validation set
using grid search, in (1) are λ1 = 0.1, λ2 = 2, λ3 = 0.3, and
λ4 = 2 for lesion detection and λ1 = 0.1, λ2 = 3, λ3 = 1,
and λ4 = 2.5 for malignant lesion detection problem. We
evaluate our methodology in terms of true positive rate
(TPR) and the number of false positive detections (FPD)
per patient, which are plotted as a free response operating
characteristic curve (FROC) (obtained by thresholding the
mask produced by MASD at different values in [0, 1]). For
each of the two problems above, we present results for two
different scenarios: 1) All: the TPRs are computed using the
total number of lesions (problem 1: lesion detection) and
the total number of malignant lesions (problem 2: malignant
lesion detection) in the dataset, and the FPDs per patient
rates are computed using the total number of patients with
lesions (problem 1), and the number of patients that have
malignant lesions (problem 2); and 2) C+: the TPRs and
FPDs are computed as above, but we disregard all volumes
classified as negative by the DenseNet classifier. The second
scenario above isolates the performance of MASD, which
is the main contribution of this paper. A true positive is
considered to be a detection if it has Dice ≥ 0.2 [11].
Finally, we provide a comparison with current SOTA weakly
supervised region detectors: CAM [7], GRAD-CAM [8] and
Guided-Grad-CAM [8].
Figure 3 shows the FROC curves for each of the problems
detailed above, and Fig. 4 shows MASD results for the lesion
detection problem in test images.
Fig. 3: FROC curves showing TPR vs FPD for lesion
detection (Top) and malignant lesion detection (Bottom)
for the All (solid curves) and C+ (dashed) experiments.
The results in Fig. 3 show that our proposed MASD
approach is more accurate for both problems of lesion
and malignant lesion detection than current SOTA saliency
visualization methods [7], [8], where only Guided-Grad-
(a) (b) (c)
Fig. 4: Detections obtained with MASD for lesion detection.
Red boxes mark true positive detections, yellow boxes false
positive detections, and cyan the ground truth boxes.
CAM [8] achieves a relatively competitive result. We believe
that the reason behind this Guided-Grad-Cam result lies in
the use of guided backpropagation that enables it to capture
the fine details of the salient regions, but the mistakes
made in low resolution are also carried over, increasing
the FPD. Using the DenseNet classification result to filter
out the negatively classified samples, all methods present
slightly improved FROC curves, where the TPR curve tends
to be consistently higher for the same rates of FPDs per
patient. Compared to strongly supervised lesion detection
approaches [11], [12], which show a TPR=0.8 for FPD=3
and TPR=0.9 for FPD=4, the MASD approach still has room
for improvement – for instance, a TPR=0.8 happens only at
FPD=8. We conjecture that more competitive results can be
achieved with significantly larger datasets, but the empirical
confirmation of this supposition is left for future work.
We tested the influence of each term in the loss function
(1) and we found that the terms that produced the largest
variation in our results were `D(.) and `A(.) because they
allowed a significant reduction in the number and size of
salient regions. The `TV (.) and `P (.) terms mainly influ-
enced the lesion detection problem by increasing the FPDs.
5. CONCLUSION
We proposed MASD, a model agnostic 1-class saliency
detector that can localize lesions in weakly supervised clas-
sification problems from breast DCE-MRI. By designing a
loss function that explicitly incorporates terms that define a
lesion (e.g. size, masked volume classification performance,
absence in negative images), we demonstrate that the de-
tected salient regions are more likely to represent the lesions
that explain the decision process of deep learning classifiers.
We believe that explaining the decision process of weakly-
supervised classifiers will become a dominating aspect in
the field because it is likely that doctors will require an
explanation that can justify a DLM classification [3].
We would like to thank Nvidia for the donation of a
TitanXp that supported this work.
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